Fabio Grassi

Fabio Grassi

Company: MV Biotherapeutics

Job title: Founder & Chief Executive Officer


Reprogramming the Microbiome in Cancer Immunotherapy 2:00 pm

Outlining the adaptive modulation of the microbiota in dysbiosis by apyrase-mediated secretory IgA amplification Exploring gut ecosystem proficiency in cancer immunotherapy by oral administration of apyraseRead more

day: Day Two Track C PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.